APDN
Price
$0.19
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
7.13M
POAI
Price
$1.21
Change
-$0.13 (-9.70%)
Updated
Jan 17 closing price
Capitalization
9.22M
Ad is loading...

APDN vs POAI

Header iconAPDN vs POAI Comparison
Open Charts APDN vs POAIBanner chart's image
Applied DNA Sciences
Price$0.19
Change-$0.00 (-0.00%)
Volume$1.34M
Capitalization7.13M
Predictive Oncology
Price$1.21
Change-$0.13 (-9.70%)
Volume$323.62K
Capitalization9.22M
APDN vs POAI Comparison Chart
Loading...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APDN vs. POAI commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDN is a Hold and POAI is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (APDN: $0.19 vs. POAI: $1.21)
Brand notoriety: APDN and POAI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APDN: 19% vs. POAI: 20%
Market capitalization -- APDN: $7.13M vs. POAI: $9.22M
APDN [@Medical Specialties] is valued at $7.13M. POAI’s [@Medical Specialties] market capitalization is $9.22M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APDN’s FA Score shows that 1 FA rating(s) are green whilePOAI’s FA Score has 0 green FA rating(s).

  • APDN’s FA Score: 1 green, 4 red.
  • POAI’s FA Score: 0 green, 5 red.
According to our system of comparison, POAI is a better buy in the long-term than APDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APDN’s TA Score shows that 4 TA indicator(s) are bullish while POAI’s TA Score has 5 bullish TA indicator(s).

  • APDN’s TA Score: 4 bullish, 2 bearish.
  • POAI’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, APDN is a better buy in the short-term than POAI.

Price Growth

APDN (@Medical Specialties) experienced а -3.19% price change this week, while POAI (@Medical Specialties) price change was -11.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

APDN is expected to report earnings on Aug 08, 2024.

POAI is expected to report earnings on May 17, 2023.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
POAI($9.22M) has a higher market cap than APDN($7.13M). POAI YTD gains are higher at: 47.561 vs. APDN (-6.176). APDN has higher annual earnings (EBITDA): -12.2M vs. POAI (-13.93M). POAI has more cash in the bank: 11.9M vs. APDN (3.36M). APDN has less debt than POAI: APDN (1.12M) vs POAI (3.16M). APDN has higher revenues than POAI: APDN (9M) vs POAI (1.81M).
APDNPOAIAPDN / POAI
Capitalization7.13M9.22M77%
EBITDA-12.2M-13.93M88%
Gain YTD-6.17647.561-13%
P/E RatioN/AN/A-
Revenue9M1.81M497%
Total Cash3.36M11.9M28%
Total Debt1.12M3.16M35%
FUNDAMENTALS RATINGS
APDN vs POAI: Fundamental Ratings
APDN
POAI
OUTLOOK RATING
1..100
1092
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
9535
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5045

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APDN's Valuation (31) in the Information Technology Services industry is in the same range as POAI (42) in the null industry. This means that APDN’s stock grew similarly to POAI’s over the last 12 months.

APDN's Profit vs Risk Rating (100) in the Information Technology Services industry is in the same range as POAI (100) in the null industry. This means that APDN’s stock grew similarly to POAI’s over the last 12 months.

APDN's SMR Rating (98) in the Information Technology Services industry is in the same range as POAI (99) in the null industry. This means that APDN’s stock grew similarly to POAI’s over the last 12 months.

POAI's Price Growth Rating (35) in the null industry is somewhat better than the same rating for APDN (95) in the Information Technology Services industry. This means that POAI’s stock grew somewhat faster than APDN’s over the last 12 months.

POAI's P/E Growth Rating (100) in the null industry is in the same range as APDN (100) in the Information Technology Services industry. This means that POAI’s stock grew similarly to APDN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APDNPOAI
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 11 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 11 days ago
79%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 11 days ago
84%
View a ticker or compare two or three
Ad is loading...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
POAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LMFA2.190.10
+4.78%
LM Funding America
MPTI55.421.91
+3.57%
M-tron Industries
UEC7.080.23
+3.36%
Uranium Energy Corp
TMP66.950.31
+0.47%
Tompkins Financial Corp
CAG25.820.03
+0.12%
Conagra Brands

APDN and

Correlation & Price change

A.I.dvisor tells us that APDN and UFPT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APDN and UFPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APDN
1D Price
Change %
APDN100%
+0.74%
UFPT - APDN
29%
Poorly correlated
+1.09%
POAI - APDN
28%
Poorly correlated
-9.70%
PRPO - APDN
27%
Poorly correlated
+5.85%
ATEC - APDN
24%
Poorly correlated
+2.48%
CODX - APDN
23%
Poorly correlated
+2.53%
More

POAI and

Correlation & Price change

A.I.dvisor tells us that POAI and MBOT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that POAI and MBOT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To POAI
1D Price
Change %
POAI100%
-9.70%
MBOT - POAI
32%
Poorly correlated
-7.87%
STSS - POAI
29%
Poorly correlated
-1.60%
LFWD - POAI
29%
Poorly correlated
-9.39%
APDN - POAI
28%
Poorly correlated
+0.74%
CNTGF - POAI
25%
Poorly correlated
N/A
More